Colorectal cancer metastatic Trials in New York, United States
Conditions / Colorectal cancer metastatic / New York, United States
Clinical trials for Colorectal cancer metastatic investigate a range of treatment strategies and patient populations.
10 total trials for this combination
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT05480306 | Phase 2 Study of DKN-01 in Colorectal Cancer | COMPLETED | PHASE2 |
| NCT01298570 | Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer | COMPLETED | PHASE2 |
| NCT05736731 | A Study to Evaluate the Safety and Efficacy of A2B530, a Logic-gated CAR T, in Participants With Solid Tumors That Express CEA and Have Lost HLA-A*02 Expression | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2 |
| NCT06300463 | Platform Study of Immunotherapy Combinations in Colorectal Cancer Liver Metastases | RECRUITING | PHASE2 |
| NCT01483027 | Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer | COMPLETED | NA |
| NCT03038568 | Assessing How Normal Variations in CT Scanning Affects Its Interpretation | ACTIVE_NOT_RECRUITING | — |
| NCT03597581 | A Study of RGX-202-01 (Ompenaclid) as Combination Therapy in RAS Mutant Advanced Colorectal Cancer | COMPLETED | PHASE1 |
| NCT04169347 | FOLFOXIRI Plus Panitumumab in Metastatic RAS Wild-type, Left-sided Colorectal Cancer | UNKNOWN | PHASE2 |
| NCT01721954 | FOLFOX6m Plus SIR-Spheres Microspheres vs FOLFOX6m Alone in Patients With Liver Mets From Primary Colorectal Cancer | COMPLETED | PHASE3 |
| NCT01053013 | Open-Label Phase 2 Efficacy Trial of Cancer Macrobeads in Patients With Treatment-Resistant Pancreatic/Colorectal Cancer | COMPLETED | PHASE2 |